NCT00295841View on ClinicalTrials.gov

Cytarabine and Clofarabine in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia

PHASE1CompletedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

February 28, 2005

Primary Completion Date

January 7, 2015

Study Completion Date

January 7, 2015

Conditions
Leukemia
Interventions
DRUG

clofarabine

DRUG

cytarabine

Trial Locations (1)

27157-1096

Wake Forest University Comprehensive Cancer Center, Winston-Salem

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Wake Forest University Health Sciences

OTHER

NCT00295841 - Cytarabine and Clofarabine in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia | Biotech Hunter | Biotech Hunter